Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
No, Rice Krispies Aren’t Bio-Toxic
If you listen to environmental activists these days, you might think that snap, crackle, and pop coming from your Rice Krispies is the…
Study
Prometheus or Pandora – Addressing the Biotechnology Issue
Biotechnology, the newest way in which man seeks to tease from nature her secrets so as to improve his condition, is under intense scrutiny today.
Op-Eds
Data Mismanagement
Members of Congress, both Republican and Democrat, now say that Sarbanes-Oxley can be unduly burdensome on business. The law that, in…
Products
New Era, or ‘Ancien Régime,’ for European Biotech?
The long-awaited World Trade Organization (WTO) decision on biotech food is due to be released this spring, but a leaked copy of the…
Products
CEI Planet: March – April 2006
Full Document Available in PDF New Era, or ‘Ancien Régime,’…
Op-Eds
Is the U.S. Sugar Problem Solvable?
The United States’ sugar policy has a long history of supporting sugar producers, and the current system has its roots in the agricultural programs of…